SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (3565)11/14/2002 5:47:30 PM
From: Qualified Opinion  Read Replies (1) of 10345
 
I didn't read any news that stated any of the AN-1792 recipients had strokes.

Excerpt from the article:

"Bill Thies, vice president for medical and scientific affairs of the Alzheimer's Association, said the new study "is an interesting paper and something that we should look at carefully."

But he said Alzheimer's vaccine therapy remains promising and research should be pursued vigorously.

"We are continuing to unravel some of the nuances of it," said Thies. "Whether it ends up being a useful therapy or not is still an open question, but it has enough promise that a lot of people are still working on it."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News